Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
The Journal of Urology|October 1, 1976
Experience with the artificial urinary sphincter at MichiganA C Diokno, M E TaubJournal of Cellular Physiology|February 1, 1992
Polarity in the transcytotic processing of apical and basal membrane-bound peroxidase-polylysine conjugates in MDCK cellsM E Taub, W C ShenJournal of Cell Science|December 1, 1993
Regulation of pathways within cultured epithelial cells for the transcytosis of a basal membrane-bound peroxidase-polylysine conjugateM E Taub, W C ShenPharmaceutical Research|September 1, 1994
Transepithelial transport of tyramine across filter-grown MDCK cells via a poly(D-lysine) carrierM E Taub, J Wan, W C ShenBiochemical Pharmacology|February 5, 2011
Effect of its deaminated metabolite, 2',2'-difluorodeoxyuridine, on the transport and toxicity of gemcitabine in HeLa cellsL S Hodge, M E Taub, T S TracyThe Journal of Biological Chemistry|July 5, 1992
Brefeldin A enhances receptor-mediated transcytosis of transferrin in filter-grown Madin-Darby canine kidney cellsJ Wan, M E Taub, D Shah, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 5, 2001
Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell lineC U Nielsen, R Andersen, B Brodin, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 11, 1999
Stability, metabolism and transport of D-Asp(OBzl)-Ala--a model prodrug with affinity for the oligopeptide transporterB Steffansen, E I Lepist, M E Taub, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 29, 2000
Stability and in vitro metabolism of dipeptide model prodrugs with affinity for the oligopeptide transporterE I Lepist, T Kusk, D H Larsen, et al.Clinical Pharmacology and Therapeutics|June 4, 2016
Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and RosuvastatinP Stopfer, T Giessmann, K Hohl, et al.Pageof 2